Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emma Weizenbaum, Ph.D.

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Learning Curve120232300.780 Why?
Video Games120211980.620 Why?
Ketoprofen1201370.460 Why?
Tromethamine12013310.460 Why?
Memory1202321930.450 Why?
Tryptamines12013930.440 Why?
Carbazoles120132200.400 Why?
Data Collection1202033220.370 Why?
Parkinson Disease2202128770.340 Why?
Headache4201612560.280 Why?
Analgesics1201310700.270 Why?
Cognition2202169920.260 Why?
Migraine Disorders2201817030.250 Why?
Feasibility Studies2202352470.190 Why?
Activities of Daily Living2202024210.170 Why?
Computers, Handheld120202100.150 Why?
Amitriptyline120161120.130 Why?
Pituitary Diseases120161350.120 Why?
Reproducibility of Results22023201000.110 Why?
Analgesics, Non-Narcotic120163700.110 Why?
Health Services120187520.110 Why?
Self Concept1201810450.100 Why?
Social Stigma120187690.100 Why?
Functional Laterality1201822570.090 Why?
Motivation1202120060.090 Why?
Boston1202393270.090 Why?
Anxiety Disorders1202127200.090 Why?
Neuropsychological Tests1202170540.080 Why?
Choice Behavior120138250.070 Why?
Physician's Role120139170.070 Why?
Neurology120147800.070 Why?
Fellowships and Scholarships1201411170.060 Why?
Patient Participation1201314450.060 Why?
Alzheimer Disease1202386010.050 Why?
Societies, Medical1201339050.050 Why?
Humans1220237615960.050 Why?
Stress Disorders, Post-Traumatic1201845750.040 Why?
Aged520231693100.040 Why?
Depression1201881260.040 Why?
Pain Clinics12016500.030 Why?
Memory Disorders1202311990.030 Why?
Random Allocation1201823950.030 Why?
Censuses120142020.030 Why?
Amyloid beta-Peptides1202338390.020 Why?
Prevalence22018157330.020 Why?
Treatment Outcome12016646850.020 Why?
Self Report1202137250.020 Why?
Demography1201416480.020 Why?
Male620183608460.020 Why?
Female620183927050.020 Why?
Positron-Emission Tomography1202364840.020 Why?
Disease Progression12023135100.020 Why?
Anxiety1202145730.020 Why?
Program Evaluation1201424950.020 Why?
Sex Factors12018105540.010 Why?
Dose-Response Relationship, Drug12016107660.010 Why?
Adult420212212100.010 Why?
Middle Aged420182209210.010 Why?
Age Factors12018183990.010 Why?
Curriculum1201437430.010 Why?
Young Adult22018592600.010 Why?
Longitudinal Studies12016146080.010 Why?
Adolescent22018883260.010 Why?
Practice Guidelines as Topic1201373910.010 Why?
United States22014723400.010 Why?
Physicians1201345910.010 Why?
Cohort Studies12016414950.010 Why?
Aged, 80 and over12018589840.010 Why?
Retrospective Studies12014806470.000 Why?
Weizenbaum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.